China Pioneer Pharma Holdings Limited (1345.HK)

HKD 2.26

(1.35%)

Net Income Summary of China Pioneer Pharma Holdings Limited

  • China Pioneer Pharma Holdings Limited's latest annual net income in 2023 was 145.71 Million CNY , down -38.07% from previous year.
  • China Pioneer Pharma Holdings Limited's latest quarterly net income in 2023 FY was 145.71 Million CNY , down -38.07% from previous quarter.
  • China Pioneer Pharma Holdings Limited reported an annual net income of 235.29 Million CNY in 2022, up 64.97% from previous year.
  • China Pioneer Pharma Holdings Limited reported an annual net income of 142.63 Million CNY in 2021, up 171.95% from previous year.
  • China Pioneer Pharma Holdings Limited reported a quarterly net income of 145.71 Million CNY for 2023 FY, down -38.07% from previous quarter.
  • China Pioneer Pharma Holdings Limited reported a quarterly net income of 77 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Net Income Chart of China Pioneer Pharma Holdings Limited (2023 - 2010)

Historical Annual Net Income of China Pioneer Pharma Holdings Limited (2023 - 2010)

Year Net Income Net Income Growth
2023 145.71 Million CNY -38.07%
2022 235.29 Million CNY 64.97%
2021 142.63 Million CNY 171.95%
2020 52.44 Million CNY -49.87%
2019 104.62 Million CNY 23.68%
2018 84.59 Million CNY -69.67%
2017 278.92 Million CNY 17.47%
2016 237.44 Million CNY 36.23%
2015 174.3 Million CNY -33.4%
2014 261.71 Million CNY 9.79%
2013 238.37 Million CNY 27.9%
2012 186.36 Million CNY 94.79%
2011 95.67 Million CNY 35.83%
2010 70.43 Million CNY 0.0%

Peer Net Income Comparison of China Pioneer Pharma Holdings Limited

Name Net Income Net Income Difference
China Healthwise Holdings Limited -134.55 Million HKD 208.294%
Tycoon Group Holdings Limited 297.31 Million HKD 50.989%
Beijing Tong Ren Tang Chinese Medicine Company Limited 540.39 Million HKD 73.035%